Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
21/11/2025
The euro/dollar extended its decline, falling 0.3% to a two-week low of 1.1498 dollars.
Latest
1 m ago
Federal Reserve Williams: Looking ahead, it is crucial to gradually restore inflation to our long-term target of 2% in a sustainable manner. Equally important is to achieve this without unnecessary risks to our maximization of employment goal. Clear communication can limit market volatility. While the central bank must achieve the 2% inflation target, it needs to do so without causing greater harm to the labor market.
2 m ago
Google (GOOGL.US) antitrust lawsuit nearing completion, seeks to avoid splitting up its advertising business.
2 m ago
Zhongke Feice: Ha Chengshu, Chen Lu, and Gu Kainan plan to reduce their holdings by 0.0357%, 0.0178%, and 0.0027% respectively.
3 m ago
Crackdown on illegal stock recommendations, stock market rumors - Shanghai holds special action to rectify online financial information chaos summary exchange event.
4 m ago
CSPC Pharmaceutical Group Limited (003020.SZ): The application for registration and listing of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets has been accepted.
See all latest